Dopamine D1 Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking

Interactions between dopaminergic and glutamatergic afferents in the striatum are essential for motor learning and the regulation of movement. An important mechanism for these interactions is the ability of dopamine, through D1 receptors, to potentiate NMDA glutamate receptor function. Here we show that, in striatal neurons, D1 receptor activation leads to rapid trafficking of NMDA receptor subunits, with increased NR1 and NR2B subunits in dendrites, enhanced coclustering of these subunits with the postsynaptic density scaffolding molecule postsynaptic density-95, and increased surface expression. The dopamine D1 receptor-mediated NMDA receptor trafficking is blocked by an inhibitor of tyrosine kinases. Blockers of tyrosine phosphatases also induce NMDA subunit trafficking, but this effect is nonselective and alters both NR2A- and NR2B-containing receptors. Furthermore, tyrosine phosphatase inhibition leads to the clustering of tyrosine-phosphorylated NR2B subunit along dendritic shafts. Our findings reveal that D1 receptor activation can potentiate striatal NMDA subunit function by directly promoting the surface insertion of the receptor complexes. This effect is regulated by the reciprocal actions of protein tyrosine phosphatases and tyrosine kinases. Modification of these pathways may be a useful therapeutic target for Parkinson’s disease and other basal ganglia disorders in which abnormal function of striatal NMDA receptors contributes to the symptoms of the diseases.

[1]  T. Chase,et al.  Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration , 1998, Brain Research.

[2]  M. Segal,et al.  Formation of dendritic spines in cultured striatal neurons depends on excitatory afferent activity , 2003, The European journal of neuroscience.

[3]  J. Partridge,et al.  Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. , 2000, Journal of neurophysiology.

[4]  T. Bliss,et al.  Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Calabresi,et al.  Long-term synaptic depression in the striatum: physiological and pharmacological characterization , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  R. Carroll,et al.  NMDA-receptor trafficking and targeting: implications for synaptic transmission and plasticity , 2002, Trends in Neurosciences.

[7]  Micaela Morelli,et al.  Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions , 1994, Trends in Neurosciences.

[8]  A. Bonci,et al.  NMDA receptor function is regulated by the inhibitory scaffolding protein, RACK1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Petralia,et al.  NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex , 2003, Nature Cell Biology.

[10]  A. Sampson,et al.  Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models , 2006, Nature Neuroscience.

[11]  J. Penney,et al.  Organization of N‐methyl‐D‐aspartate glutamate receptor gene expression in the basal ganglia of the rat , 1994, The Journal of comparative neurology.

[12]  David G Standaert,et al.  Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. , 2004, Molecular pharmacology.

[13]  Paul Greengard,et al.  Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. , 2002, Journal of neurophysiology.

[14]  Y. Smith,et al.  Microcircuitry of the direct and indirect pathways of the basal ganglia. , 1998, Neuroscience.

[15]  M. Sheng,et al.  Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization , 2000, Nature Neuroscience.

[16]  S. Komai,et al.  Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. , 2001, The Journal of biological chemistry.

[17]  R. Weinberg,et al.  Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting. , 2002, Neuron.

[18]  Brian J Bacskai,et al.  Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Hoogenraad,et al.  LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses , 2005, Nature Neuroscience.

[20]  R. Huganir,et al.  Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions , 1995, Neuroreport.

[21]  Paul Greengard,et al.  Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.

[22]  Charles J. Wilson,et al.  Striatal interneurones: chemical, physiological and morphological characterization , 1995, Trends in Neurosciences.

[23]  R. Weinberg,et al.  Interaction between GRIP and Liprin-α/SYD2 Is Required for AMPA Receptor Targeting , 2002, Neuron.

[24]  B. Hyman,et al.  Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and β-Secretase β-Site APP-Cleaving Enzyme , 2006, The Journal of Neuroscience.

[25]  T. Suzuki,et al.  NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain. , 1995, Biochemical and biophysical research communications.

[26]  J. Bolam,et al.  Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  J. Wickens,et al.  Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. , 2001, Journal of neurophysiology.

[28]  P. Calabresi,et al.  Striatal synaptic plasticity: Implications for motor learning and Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[29]  G. Banker,et al.  Culturing nerve cells , 1998 .

[30]  M. Sheng,et al.  Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity , 2004, Science.

[31]  Y. Jan,et al.  Changing subunit composition of heteromeric NMDA receptors during development of rat cortex , 1994, Nature.

[32]  Kai Chang,et al.  The Synaptic Localization of NR2B-Containing NMDA Receptors Is Controlled by Interactions with PDZ Proteins and AP-2 , 2005, Neuron.

[33]  R. Wenthold,et al.  The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1 , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  B. Sakmann,et al.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.

[35]  T. Chase,et al.  Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism , 2000, Trends in Neurosciences.

[36]  Shoji Komai,et al.  Characterization of Fyn-mediated Tyrosine Phosphorylation Sites on GluRε2 (NR2B) Subunit of theN-Methyl-d-aspartate Receptor* , 2001, The Journal of Biological Chemistry.

[37]  D. Henze,et al.  Clozapine Potentiation of N-Methyl-d-aspartate Receptor Currents in the Nucleus Accumbens: Role of NR2B and Protein Kinase A/Src Kinases , 2005, Journal of Pharmacology and Experimental Therapeutics.

[38]  Y. Dudai,et al.  Long-term potentiation increases tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit 2B in rat dentate gyrus in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Yasuda,et al.  Developmental Regulation of Tyrosine Phosphorylation of the NR2D NMDA Glutamate Receptor Subunit in Rat Central Nervous System , 1998, Journal of neurochemistry.

[40]  H. C. Cromwell,et al.  Modulatory Actions of Dopamine on NMDA Receptor-Mediated Responses Are Reduced in D1A-Deficient Mutant Mice , 1996, The Journal of Neuroscience.

[41]  S. Sherman,et al.  Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture , 2006, The Journal of comparative neurology.

[42]  T. Chase Striatal plasticity and extrapyramidal motor dysfunction. , 2004, Parkinsonism & related disorders.

[43]  Mary B. Kennedy,et al.  The postsynaptic density at glutamatergic synapses , 1997, Trends in Neurosciences.

[44]  E. Molnár,et al.  Assembly intracellular targeting and cell surface expression of the human N-methyl-d-aspartate receptor subunits NR1a and NR2A in transfected cells , 1998, Neuropharmacology.

[45]  J. Penney,et al.  Expression of N‐Methyl‐D‐Aspartate receptor subunit mRNAs in the human brain: Striatum and globus pallidus , 1998, The Journal of comparative neurology.

[46]  S. Vicini,et al.  Characterization of NMDA Receptor Subunit‐Specific Antibodies: Distribution of NR2A and NR2B Receptor Subunits in Rat Brain and Ontogenic Profile in the Cerebellum , 1995, Journal of neurochemistry.

[47]  S. Coultrap,et al.  LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1 , 2002, Nature Neuroscience.

[48]  R. Petralia,et al.  Trafficking of NMDA receptors. , 2003, Annual review of pharmacology and toxicology.

[49]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.

[50]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[51]  D. Standaert,et al.  Rationale for and use of NMDA receptor antagonists in Parkinson's disease. , 2004, Pharmacology & therapeutics.

[52]  T. Soderling,et al.  Differential Surface Expression and Phosphorylation of the N-Methyl-D-aspartate Receptor Subunits NR1 and NR2 in Cultured Hippocampal Neurons* , 1997, The Journal of Biological Chemistry.

[53]  Brian J. Bacskai,et al.  Amyloid Precursor Protein Associates with a Nicastrin-Dependent Docking Site on the Presenilin 1–γ-Secretase Complex in Cells Demonstrated by Fluorescence Lifetime Imaging , 2003, The Journal of Neuroscience.

[54]  J. Hell,et al.  A Developmental Change in NMDA Receptor-Associated Proteins at Hippocampal Synapses , 2000, The Journal of Neuroscience.

[55]  P. Calabresi,et al.  Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. , 2005, Neurotoxicology.

[56]  P. Calabresi,et al.  Distinct Roles of D1 and D5 Dopamine Receptors in Motor Activity and Striatal Synaptic Plasticity , 2003, The Journal of Neuroscience.

[57]  Takayoshi Suzuki,et al.  NMDA Receptor Subunits ϵ1 (NR2A) and ϵ2 (NR2B) Are Substrates for Fyn in the Postsynaptic Density Fraction Isolated from the Rat Brain , 1995 .

[58]  Angus C. Nairn,et al.  The Dopamine/D1 Receptor Mediates the Phosphorylation and Inactivation of the Protein Tyrosine Phosphatase STEP via a PKA-Dependent Pathway , 2000, The Journal of Neuroscience.

[59]  C. Cepeda,et al.  Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. , 1998, Journal of neurophysiology.

[60]  A. Parent,et al.  Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey , 1994, The Journal of comparative neurology.

[61]  C. Cepeda,et al.  Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  P. Wahle,et al.  Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[63]  P. Calabresi,et al.  Unilateral dopamine denervation blocks corticostriatal LTP. , 1999, Journal of neurophysiology.

[64]  R. Huganir,et al.  Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. , 2000, Molecular pharmacology.

[65]  R. Huganir,et al.  Differential Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptor Subunits (*) , 1995, The Journal of Biological Chemistry.

[66]  K. Roche,et al.  Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression , 2003, Neuropharmacology.

[67]  Rand Askalan,et al.  Tyrosine Phosphatase STEP Is a Tonic Brake on Induction of Long-Term Potentiation , 2002, Neuron.

[68]  D. Standaert,et al.  Dopamine D1 Receptor-Dependent Trafficking of Striatal NMDA Glutamate Receptors to the Postsynaptic Membrane , 2001, The Journal of Neuroscience.

[69]  E. Bézard,et al.  Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease , 2005, Neuropharmacology.

[70]  M. Kennedy,et al.  The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  N. Hirokawa,et al.  Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. , 2000, Science.

[72]  Y. Smith,et al.  Anatomy of the dopamine system in the basal ganglia , 2000, Trends in Neurosciences.